XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $1.31M invested in XTL Biopharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$1K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$1.16M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.16M | 200,234 | -7,805 | -4% |
|
2
Invesco
Atlanta,
Georgia
| $151K | 25,962 | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | 120 | -40 | -25% |
|
|
4
Morgan Stanley
New York
| $1K | 120 | +118 | +5,900% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | – | -3,172 | Closed |
|